Instituto Superior de Investigaciones Biológicas (INSIBIO), CONICET-UNT and Instituto de Química Biológica "Dr. Bernabé Bloj", Facultad de Bioquímica, Química y Farmacia, UNT, Chacabuco 461, T4000ILI San Miguel de Tucumán, Argentina.
Departamento de Bioquímica e Tecnologia Química, Instituto de Química, UNESP-Univ Estadual Paulista, Araraquara, SP, Brazil.
Biochim Biophys Acta Gen Subj. 2017 Jul;1861(7):1770-1776. doi: 10.1016/j.bbagen.2017.03.014. Epub 2017 Mar 18.
Enterocin CRL35 is a class IIa bacteriocin with anti-Listeria activity. Resistance to these peptides has been associated with either the downregulation of the receptor expression or changes in the membrane and cell walls. The scope of the present work was to characterize enterocin CRL35 resistant Listeria strains with MICs more than 10,000 times higher than the MIC of the WT sensitive strain.
Listeria monocytogenes INS7 resistant isolates R2 and R3 were characterized by 16S RNA gene sequencing and rep-PCR. Bacterial growth kinetic was studied in different culture media. Plasma membranes of sensitive and resistant bacteria were characterized by FTIR and Langmuir monolayer techniques.
The growth kinetic of the resistant isolates was slower as compared to the parental strain in TSB medium. Moreover, the resistant isolates barely grew in a glucose-based synthetic medium, suggesting that these cells had a major alteration in glucose transport. Resistant bacteria also had alterations in their cell wall and, most importantly, membrane lipids. In fact, even though enterocin CRL35 was able to bind to the membrane-water interface of both resistant and parental sensitive strains, this peptide was only able to get inserted into the latter membranes.
These results indicate that bacteriocin receptor is altered in combination with membrane structural modifications in enterocin CRL35-resistant L. monocytogenes strains.
Highly enterocin CRL35-resistant isolates derived from Listeria monocytogenes INS7 have not only an impaired glucose transport but also display structural changes in the hydrophobic core of their plasma membranes.
肠球菌素 CRL35 是一种具有抗李斯特菌活性的 IIa 类细菌素。对这些肽的抗性与受体表达的下调或细胞膜和细胞壁的变化有关。本工作的范围是表征 MIC 值比 WT 敏感株高出 10000 多倍的肠球菌素 CRL35 耐药李斯特菌菌株。
通过 16S RNA 基因测序和 rep-PCR 对单核细胞增生李斯特菌 INS7 耐药分离株 R2 和 R3 进行了表征。在不同的培养基中研究了细菌的生长动力学。通过傅里叶变换红外光谱(FTIR)和 Langmuir 单层技术对敏感菌和耐药菌的质膜进行了表征。
与亲本菌株相比,耐药分离株在 TSB 培养基中的生长动力学较慢。此外,耐药分离株在基于葡萄糖的合成培养基中几乎不生长,表明这些细胞在葡萄糖转运方面发生了重大改变。耐药菌的细胞壁也发生了改变,最重要的是,质膜脂质也发生了改变。事实上,尽管肠球菌素 CRL35 能够与耐药菌和亲本敏感菌的膜-水界面结合,但该肽只能插入后者的膜中。
这些结果表明,在肠球菌素 CRL35 耐药单核细胞增生李斯特菌菌株中,细菌素受体发生了改变,并与细胞膜结构的改变相结合。
从单核细胞增生李斯特菌 INS7 中分离出的高度肠球菌素 CRL35 耐药株不仅葡萄糖转运受损,而且其质膜疏水区的结构也发生了变化。